| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $849,974 | 3 | 13 |
Sells | $13,916,330 | 20 | 87 |
| JENKINS GEORGE M | director | 2 | $549,974 | 6 | $7.75M | $-7.2M |
| HERON ELAINE J | director | 1 | $300,000 | 0 | $0 | $300,000 |
| KIRITSY CHRISTOPHER P | director | 0 | $0 | 1 | $49,141 | $-49,141 |
| Goin Kathleen | Chief Operating Officer | 0 | $0 | 13 | $6.12M | $-6.12M |
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific …
Over the last 12 months, insiders at Palvella Therapeutics, Inc. have bought $849,974 and sold $13.92M worth of Palvella Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Palvella Therapeutics, Inc. have bought $501,245 and sold $13.92M worth of stock each year.
Highest buying activity among insiders over the last 12 months: JENKINS GEORGE M (director) — $549,974. HERON ELAINE J (director) — $300,000.
The last purchase of 445 shares for transaction amount of $49,974 was made by JENKINS GEORGE M (director) on 2026‑03‑30.
| 2026-10-21 | Sale | Goin Kathleen | Chief Operating Officer | 4,313 0.0295% | $124.58 | $537,307 | +15.46% | |
| 2026-10-14 | Sale | JENKINS GEORGE M | director | 7,174 0.0504% | $123.49 | $885,914 | +3.57% | |
| 2026-10-13 | Sale | JENKINS GEORGE M | director | 7,174 0.0507% | $130.36 | $935,232 | -1.50% | |
| 2026-10-12 | Sale | JENKINS GEORGE M | director | 13,152 0.0911% | $133.69 | $1.76M | -5.52% | |
| 2026-09-16 | Sale | Goin Kathleen | Chief Operating Officer | 4,302 0.0302% | $152.24 | $654,923 | -11.74% | |
| 2026-09-15 | Sale | JENKINS GEORGE M | director | 1,777 0.0123% | $150.14 | $266,806 | -11.14% | |
| 2026-09-14 | Sale | JENKINS GEORGE M | director | 13,352 0.0932% | $151.96 | $2.03M | -10.24% | |
| 2026-09-11 | Sale | JENKINS GEORGE M | director | 12,371 0.0868% | $151.28 | $1.87M | -8.13% | |
| 2026-09-02 | Sale | KIRITSY CHRISTOPHER P | director | 313 0.0022% | $157.00 | $49,141 | -9.12% | |
| 2026-08-19 | Sale | Goin Kathleen | Chief Operating Officer | 4,302 0.0304% | $152.21 | $654,791 | -2.59% | |
| 2026-07-15 | Sale | Goin Kathleen | Chief Operating Officer | 522 0.0043% | $147.14 | $76,805 | -3.34% | |
| 2026-07-15 | Sale | Goin Kathleen | Chief Operating Officer | 4,302 0.0357% | $149.28 | $642,191 | -3.34% | |
| 2026-06-17 | Sale | Goin Kathleen | Chief Operating Officer | 4,302 0.0357% | $110.73 | $476,373 | +29.73% | |
| 2026-05-20 | Sale | Goin Kathleen | Chief Operating Officer | 4,302 0.0348% | $110.56 | $475,631 | +23.46% | |
| 2026-04-15 | Sale | Goin Kathleen | Chief Operating Officer | 4,302 0.036% | $127.24 | $547,399 | +7.35% | |
| 2026-03-30 | JENKINS GEORGE M | director | 445 0.0038% | $112.30 | $49,974 | +19.94% | ||
| 2026-03-18 | Sale | Goin Kathleen | Chief Operating Officer | 4,302 0.0375% | $117.99 | $507,611 | +14.37% | |
| 2026-02-27 | JENKINS GEORGE M | director | 4,000 0.0313% | $125.00 | $500,000 | -2.36% | ||
| 2026-02-27 | HERON ELAINE J | director | 2,400 0.0188% | $125.00 | $300,000 | -2.36% | ||
| 2026-02-18 | Sale | Goin Kathleen | Chief Operating Officer | 4,302 0.0363% | $79.40 | $341,564 | +65.00% |
| JENKINS GEORGE M | director | 132616 0.9204% | $20.28M | 4 | 6 | +177.13% |
| HERON ELAINE J | director | 47812 0.3318% | $7.31M | 1 | 0 |
$21,345,882 | 83 | 94.45% | $2.19B | |
$52,263,649 | 70 | 1.18% | $2.49B | |
$1,376,668 | 53 | 18.46% | $2.1B | |
$108,353,116 | 49 | 15.41% | $2.17B | |
$586,486,795 | 47 | 4.28% | $2.38B |
| Increased Positions | 96 | +98.97% | 3M | +35.1% |
| Decreased Positions | 41 | -42.27% | 2M | -20.61% |
| New Positions | 54 | New | 1M | New |
| Sold Out Positions | 12 | Sold Out | 523,349 | Sold Out |
| Total Postitions | 152 | +56.7% | 10M | +14.48% |